Related Experiment Video
Updated: Feb 24, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Internet-Delivered Cognitive Behavioral Therapy for Children With Pain-Related Functional Gastrointestinal Disorders:
Maria Lalouni1,2, Brjánn Ljótsson3,4, Marianne Bonnert2,3,5
1Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Insights
Internet-delivered cognitive behavior therapy (Internet-CBT) is a feasible and effective treatment for children with pain-related functional gastrointestinal disorders (P-FGIDs). This therapy significantly improved symptoms and quality of life, with results sustained at six months.
Area of Science:
- Pediatric Gastroenterology
- Child Psychology
- Digital Health Interventions
Background:
- Pain-related functional gastrointestinal disorders (P-FGIDs) are common in children, impacting quality of life and leading to anxiety and school absence.
- Current treatment options for pediatric P-FGIDs are limited, necessitating the development of accessible and effective therapies.
- Internet-delivered cognitive behavior therapy (Internet-CBT) has shown efficacy in adults and adolescents but requires evaluation in younger children.
Purpose of the Study:
- To assess the acceptability and feasibility of Internet-CBT for children aged 8-12 with P-FGIDs.
- To evaluate the potential clinical efficacy of this digital intervention in improving gastrointestinal symptoms and related outcomes.
- To determine if parents find the intervention acceptable and if it aids in managing their child's pain behaviors.
Main Methods:
- A feasibility study with a within-group design included 31 children (8-12 years) diagnosed with P-FGID (ROME III criteria).
- Participants underwent 10 weekly modules of therapist-guided, exposure-based Internet-CBT, focusing on symptom provocation and avoidance behaviors.
- Parental involvement included reducing attention to pain behaviors and reinforcing exposure work; outcomes were assessed pre- and post-treatment, and at 6-month follow-up.
Main Results:
- High treatment completion rates (81%) and significant child-reported symptom improvement (87%) were observed.
- A large effect size (Cohen d=1.14) for child-rated gastrointestinal symptoms was noted from pre- to post-treatment, maintained at 6-month follow-up (d=1.40).
- Significant improvements were recorded in quality of life, pain intensity, anxiety, depression, and school absence, with sustained or further improved results at follow-up.
Conclusions:
- Exposure-based Internet-CBT is perceived as acceptable and feasible by children with P-FGIDs and their parents.
- The intervention demonstrated significant clinical efficacy, improving symptoms and associated functional impairments even in children with long-standing conditions.
- Further confirmation in a randomized controlled trial (RCT) is warranted to solidify these promising findings for pediatric P-FGIDs.
Background:
Pain-related functional gastrointestinal disorders (P-FGIDs; eg, irritable bowel syndrome) are highly prevalent in children and associated with low quality of life, anxiety, and school absence. Treatment options are scarce, and there is a need for effective and accessible treatments. Internet-delivered cognitive behavior therapy (Internet-CBT) based on exposure exercises is effective for adult and adolescent irritable bowel syndrome, but it has not been evaluated for younger children.
Objective:
The objective of this study was to assess acceptability, feasibility, and potential clinical efficacy of Internet-CBT for children with P-FGIDs.
Methods:
This was a feasibility study with a within-group design. We included 31 children aged 8-12 years and diagnosed with P-FGID, according to the ROME III criteria. Mean duration of abdominal symptoms at baseline was 3.8 years (standard deviation [SD] 2.6). The treatment was therapist-guided and consisted of 10 weekly modules of exposure-based Internet-CBT. The children were instructed to provoke abdominal symptoms in a graded manner and to engage in previously avoided activities. The parents were taught to decrease their attention to their children's pain behaviors and to reinforce and support their work with the exposures. Assessments included treatment satisfaction, subjective treatment effect, gastrointestinal symptoms, quality of life, pain intensity, anxiety, depression, and school absence. Data were collected at pretreatment, posttreatment, and 6-month follow-up. Means, standard errors (SEs), and Cohen d effect sizes were estimated based on multi-level linear mixed models.
Results:
Most children 25/31 (81%) completed 9 or 10 of the 10 treatment modules. Almost all children, 28/31 (90%), reported that the treatment had helped them to deal more effectively with their symptoms, and 27/31 (87%) children declared that their symptoms had improved during the treatment. Assessments from the parents were in accordance with the children's reports. No child or parent reported that the symptoms had worsened. We observed a large within-group effect size on the primary outcome measure, child-rated gastrointestinal symptoms from pretreatment to posttreatment (Cohen d=1.14, P<.001, 95% CI 0.69-1.61), and this effect size was maintained at 6-month follow-up (Cohen d=1.40, P<.001, 95% CI 1.04-1.81). We also observed significant improvements from pretreatment to posttreatment on a wide range of child- and parent-rated measures including quality of life, pain intensity, anxiety, depression, and school absence. All results remained stable or were further improved at 6-month follow-up.
Conclusions:
This study shows that children with longstanding P-FGIDs, and their parents, perceive exposure-based Internet-CBT as a helpful and feasible treatment. The included children improved significantly despite a long duration of abdominal symptoms before the intervention. The treatment shows potential to be highly effective for P-FGIDs. The results need to be confirmed in a randomized controlled trial (RCT).
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

